Cervical cancer remains one of the most common malignancies in women, ranking as the fourth most prevalent cancer worldwide. Most cases are caused by high-risk strains of human papillomavirus (HPV), ...

HR biomarker testing is primarily done via immunohistochemistry (IHC) and detects the presence of estrogen receptors (ERs) and progesterone receptors (PRs) on cancer cells. Breast cancers that test ...

LPU study opens new avenues for cancer research and treatment: Our Bureau, Bengaluru Thursday, August 28, 2025, 14:50 Hrs [IST] Lovely Professional University (LPU) researchers at ...

Damon Runyon gave me the freedom to pursue a high-risk project,” said current Fellow Zeda Zhang, PhD. “But it also brings together smart people with very different expertise. And by creating this ...

WPBF 25 goes "On the Record" on how local medical facilities are combating cancer.

An international team led by researchers at Lund University in Sweden has identified the molecular tools needed to reprogram ordinary cells into ...

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest forms of cancer, largely driven by mutations in the KRAS gene—once considered impossible to target.

Our four core-funded institutes provide an exceptional environment for discovery research and are home to 160+ research groups working in cancer science.

Some might say it looks like a finger. Others might see a worm. Scientists in the field often liken it to an antenna. The technical name is primary cilium. This slender, microscopic appendage juts out ...

Inter-patient tumor heterogeneity refers to transcriptional differences between cancer cells of different patients. Because of their distinct mutational histories, spatial location and interactions ...

The trial will assess if shorter radiation matches current outcomes in muscle-invasive bladder cancer, using Signatera for MRD monitoring.

With fewer science students and researchers considering the US as a destination, there is concern of a brain drain from the American STEM community. Host Carolyn Beeler speaks with Marc Zimmer, ...